WallStreetZenWallStreetZen

NASDAQ: NVOS
Novo Integrated Sciences Inc Stock

$0.13-0.01 (-7.14%)
Updated Feb 3, 2023
NVOS Price
$0.13
Fair Value Price
$0.56
Market Cap
$4.13M
52 Week Low
$0.10
52 Week High
$3.32
P/E
-0.3x
P/B
0.09x
P/S
2.71x
PEG
N/A
Dividend Yield
N/A
Revenue
$22.58M
Earnings
-$12.36M
Gross Margin
26%
Operating Margin
-46.32%
Profit Margin
-54.8%
Debt to Equity
0.62
Operating Cash Flow
-$7M
Beta
2.61
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

NVOS Overview

Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary health care related products and services. It operates through two segments, Healthcare Services, and Product Manufacturing and Development. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic health program, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning program, and private personal training services. It also engages in the assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of various orthopedic, musculoskeletal, sports injury, and neurological conditions across various demographics, including pediatric, adult, and geriatric populations. In addition, the company offers eldercare physiotherapy services, such as long-term care homes, retirement homes, community based home care physiotherapy, community based group exercise classes and fall prevention programs, and community-based outpatient clinics; and elderly occupational therapy services for retirement home and community, and long-term care sectors. Further, it offers medical technology services, such as telemedicine and remote patient monitoring; and develops and distributes personalized health and wellness product solutions. The company operates 16 owned clinics. The company was incorporated in 2000 and is based in Bellevue, Washington. Novo Integrated Sciences, Inc. operates as a subsidiary of ALMC-ASAP Holdings, Inc.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NVOS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NVOS ($0.13) is undervalued by 76.17% relative to our estimate of its Fair Value price of $0.56 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
NVOS ($0.13) is significantly undervalued by 76.17% relative to our estimate of its Fair Value price of $0.56 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
NVOS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more NVOS due diligence checks available for Premium users.

Be the first to know about important NVOS news, forecast changes, insider trades & much more!

NVOS News

Valuation

NVOS fair value

Fair Value of NVOS stock based on Discounted Cash Flow (DCF)
Price
$0.13
Fair Value
$0.56
Undervalued by
76.71%
NVOS ($0.13) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
NVOS ($0.13) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
NVOS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

NVOS price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.3x
Industry
12.32x
Market
15.09x

NVOS price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.09x
Industry
4.9x
NVOS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

NVOS's financial health

Profit margin

Revenue
$13.9M
Net Income
-$3.8M
Profit Margin
-27.5%
NVOS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
NVOS's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$71.8M
Liabilities
$27.4M
Debt to equity
0.62
NVOS's short-term assets ($20.08M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NVOS's short-term assets ($20.08M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NVOS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
NVOS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$3.6M
Investing
$325.9k
Financing
-$37.2k
NVOS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

NVOS vs Medical Care Facility Stocks

TickerMarket Cap1d %P/EP/B
NVOS$4.13M-1.48%-0.30x0.09x
IONM$5.29M-10.90%-0.42x0.20x
RHE$6.01M+7.94%-0.42x1.02x
SSY$6.05M+0.94%-1.09x0.34x
BACK$10.84M+2.48%-0.53x0.94x

Novo Integrated Sciences Stock FAQ

What is Novo Integrated Sciences's quote symbol?

NASDAQ: NVOS) Novo Integrated Sciences trades on the NASDAQ under the ticker symbol NVOS. Novo Integrated Sciences stock quotes can also be displayed as NASDAQ: NVOS.

If you're new to stock investing, here's how to buy Novo Integrated Sciences stock.

What is the 52 week high and low for Novo Integrated Sciences (NASDAQ: NVOS)?

(NASDAQ: NVOS) Novo Integrated Sciences's 52-week high was $3.32, and its 52-week low was $0.10. It is currently -95.99% from its 52-week high and 31.68% from its 52-week low.

How much is Novo Integrated Sciences stock worth today?

(NASDAQ: NVOS) Novo Integrated Sciences currently has 31,021,645 outstanding shares. With Novo Integrated Sciences stock trading at $0.13 per share, the total value of Novo Integrated Sciences stock (market capitalization) is $4.13M.

Novo Integrated Sciences stock was originally listed at a price of $0.40 in Dec 11, 2020. If you had invested in Novo Integrated Sciences stock at $0.40, your return over the last 2 years would have been -66.75%, for an annualized return of -42.34% (not including any dividends or dividend reinvestments).

How much is Novo Integrated Sciences's stock price per share?

(NASDAQ: NVOS) Novo Integrated Sciences stock price per share is $0.13 today (as of Feb 3, 2023).

What is Novo Integrated Sciences's Market Cap?

(NASDAQ: NVOS) Novo Integrated Sciences's market cap is $4.13M, as of Feb 6, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Novo Integrated Sciences's market cap is calculated by multiplying NVOS's current stock price of $0.13 by NVOS's total outstanding shares of 31,021,645.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.